Literature DB >> 28078193

Metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline.

Maggie Wang1, Jennifer E Norman2, Vivek J Srinivasan3, John C Rutledge2.   

Abstract

White Matter Disease is increasingly being recognized as an important cause of cognitive decline and dementia. Various investigations have linked chronic diet-related conditions to the development of white matter lesions, which appear as white matter hyperintensities on T2-weighted magnetic resonance imaging (MRI) scans of the brain. Thus, it can be postulated that the metabolic, inflammatory, and microvascular changes accompanying a western diet, hyperlipidemia, hypertension, and diabetes mellitus type II (DMII) are potential mediators in the development and progression of white matter disease, which in turn contributes to the development and progression of cognitive decline. This review will examine evidence for potential metabolic, inflammatory, and microvascular determinants of white matter disease and cognitive decline. Specifically, we will focus on the effects of altered insulin signaling in diabetes, obesity-induced oxidative stress, neuroinflammation, arterial stiffness due to hypertension, ischemia secondary to cerebral small vessel disease, and blood brain barrier disturbances.

Entities:  

Keywords:  Alzheimer’s disease; cognitive impairment; dementia; inflammation; neurodegenerative disorders; vascular biology; western diet; white matter disease

Year:  2016        PMID: 28078193      PMCID: PMC5218857     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  50 in total

1.  Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

Authors:  L F Lue; D G Walker; L Brachova; T G Beach; J Rogers; A M Schmidt; D M Stern; S D Yan
Journal:  Exp Neurol       Date:  2001-09       Impact factor: 5.330

Review 2.  Insulin and the blood-brain barrier.

Authors:  Stephen C Woods; Randy J Seeley; Denis G Baskin; Michael W Schwartz
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

3.  Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet.

Authors:  Linnea R Freeman; Ann-Charlotte E Granholm
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-23       Impact factor: 6.200

4.  Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin.

Authors:  C G Jolivalt; C A Lee; K K Beiswenger; J L Smith; M Orlov; M A Torrance; E Masliah
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

5.  Brain perfusion and cognitive function changes in hypertensive patients.

Authors:  Irina Yu Efimova; Nataliya Yu Efimova; Sergey V Triss; Yuri B Lishmanov
Journal:  Hypertens Res       Date:  2008-04       Impact factor: 3.872

6.  Obesity increases cerebrocortical reactive oxygen species and impairs brain function.

Authors:  Linnea R Freeman; Le Zhang; Anand Nair; Kalavathi Dasuri; Joseph Francis; Sun-Ok Fernandez-Kim; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2012-10-29       Impact factor: 7.376

7.  Indirect measures of arterial stiffness and cognitive performance in individuals without traditional vascular risk factors or disease.

Authors:  Jose Gutierrez; Randolph S Marshall; Ronald M Lazar
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

8.  Increased brain fatty acid uptake in metabolic syndrome.

Authors:  Anna Karmi; Patricia Iozzo; Antti Viljanen; Jussi Hirvonen; Barbara A Fielding; Kirsi Virtanen; Vesa Oikonen; Jukka Kemppainen; Tapio Viljanen; Letizia Guiducci; Merja Haaparanta-Solin; Kjell Någren; Olof Solin; Pirjo Nuutila
Journal:  Diabetes       Date:  2010-06-21       Impact factor: 9.461

9.  C-Reactive Protein, Advanced Glycation End Products, and Their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment.

Authors:  Malgorzata Gorska-Ciebiada; Malgorzata Saryusz-Wolska; Anna Borkowska; Maciej Ciebiada; Jerzy Loba
Journal:  Front Aging Neurosci       Date:  2015-10-29       Impact factor: 5.750

10.  Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention.

Authors:  Mark A Espeland; Kirk Erickson; Rebecca H Neiberg; John M Jakicic; Thomas A Wadden; Rena R Wing; Lisa Desiderio; Guray Erus; Meng-Kang Hsieh; Christos Davatzikos; Barbara J Maschak-Carey; Paul J Laurienti; Kathryn Demos-McDermott; R Nick Bryan
Journal:  Diabetes Care       Date:  2016-03-29       Impact factor: 19.112

View more
  23 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  Saul Martinez-Horta; Jaime Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2019-04-08       Impact factor: 3.575

2.  Neurocognition in treatment-resistant hypertension: profile and associations with cardiovascular biomarkers.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Stephanie M Mabe; Jeanne E Schwartz; Forgive Avorgbedor; Andrew Sherwood
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

Review 3.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

Review 4.  Blood-Brain Barriers in Obesity.

Authors:  Elizabeth M Rhea; Therese S Salameh; Aric F Logsdon; Angela J Hanson; Michelle A Erickson; William A Banks
Journal:  AAPS J       Date:  2017-04-10       Impact factor: 4.009

5.  Clinical and MRI features about two types of silent cerebral small-vessel disease in type-2 diabetes mellitus: a retrospective cross-sectional study in a tertiary hospital.

Authors:  Dan-Qiong Wang; Lei Wang; Xiao-Shuang Xia; Miao-Miao Wei; Xiao-Lin Tian; Liang-Fang Wang; Xin Li
Journal:  Quant Imaging Med Surg       Date:  2022-04

6.  Obstructive sleep apnea and white matter hyperintensities: correlation or causation?

Authors:  Noah C Schammel; Trevor VandeWater; Stella Self; Christopher Wilson; Christine M G Schammel; Ronald Cowley; Dominic B Gault; Lee A Madeline
Journal:  Brain Imaging Behav       Date:  2022-02-26       Impact factor: 3.224

7.  A single meal has the potential to alter brain oxylipin content.

Authors:  J E Norman; H H Aung; Y Otoki; Z Zhang; A Y Taha; J C Rutledge
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-01-30       Impact factor: 4.006

8.  Cardiovascular risks impact human brain N-acetylaspartate in regionally specific patterns.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Hongji Chen; Andrew A Maudsley; Sulaiman Sheriff; Shuo Chen; Anya Savransky; Wyatt Marshall; Meghann C Ryan; Heather A Bruce; Alan R Shuldiner; Braxton D Mitchell; Peter Kochunov; L Elliot Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-21       Impact factor: 11.205

9.  COGNITOMICS: a new approach for the evaluation of the relationship between diseases and cognition to be designed based on normal behavioral tendencies in real life, a conceptual framework.

Authors:  Ata Pourabbasi; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2017-05-15

10.  Association of Blood Pressure, White Matter Lesions, and Regional Cerebral Blood Flow.

Authors:  Dong Zhang; Jianyu Zhang; Bo Zhang; Jin Zhang; Mingli He
Journal:  Med Sci Monit       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.